Publications



Results 1-36 of 36 (Search time: 0.184 seconds).

Issue DateTitleAuthor(s)SourcescopusWOSFulltext/Archive link
12022Randomized controlled trial of early endoscopy for upper gastrointestinal bleeding in acute coronary syndrome patientsChung, Chen-Shuan; Chen, Chieh-Chang; Chen, Kuan-Chih; YU-JEN FANG ; Hsu, Wen-Feng; YEN-NIEN CHEN; Tseng, Wei-Chuang; Lin, Cheng-Kuan; Lee, Tzong-Hsi; Wang, Hsiu-Po; Wu, Yen-WenScientific reports2
22022Declining trends of prevalence of Helicobacter pylori infection and incidence of gastric cancer in Taiwan: An updated cross-sectional survey and meta-analysisChen, Mei-Jyh; Bair, Ming-Jong; Chen, Po-Yueh; Lee, Ji-Yuh; Yang, Tsung-Hua; YU-JEN FANG ; Chen, Chieh-Chang; Chang, An-Ti; Hsiao, Wang-De; Yu, Jian-Jyun; Kuo, Chia-Chi; Chiu, Min-Chin; Lin, Kun-Pei; Tsai, Min-Horn; Hsu, Yao-Chun; Chou, Chu-Kuang; Chen, Chi-Yi; Lin, Jaw-Town; Lee, Yi-Chia; Wu, Ming-Shiang; Liou, Jyh-MingHelicobacter1
32021Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in TaiwanLiu C.-H.; Chen P.-Y.; Chen J.-J.; Lo C.-C.; Su W.-W.; Tseng K.-C.; Liu C.-J.; Huang C.-S.; Huang K.-J.; Yang S.-S.; Peng C.-Y.; Tsai M.-C.; Kao W.-Y.; Chang C.-Y.; Shih Y.-L.; YU-JEN FANG ; Chen C.-Y.; Lee P.-L.; Huang J.-J.; Su P.-Y.; Tseng C.-W.; Hung C.-C.; Chang C.-H.; Huang Y.-J.; Lai H.-C.; Chang C.-C.; Lee F.-J.; Hsieh T.‐Y.; Kao J.-H.Hepatology International65
42021Community-Based Gastric Cancer Screening Coupled With a National Colorectal Cancer Screening Program: Baseline ResultsLee Y.-C.; Chiang T.-H.; Chiu H.-M.; Wu M.-S.; Yeh Y.-P.; Hsiu-Hsi Chen T.; Li-Sheng Chen S.; Ming-Fang Yen A.; Ching-Yuan Fann J.; Yueh-Hsia Chiu S.; Hsu C.-Y.; Chuang S.-L.; Chou K.-C.; Su W.-W.; Chen S.-T.; Liao C.-S.; Lin Y.-M.; Chang H.-C.; Hu T.-H.; YU-JEN FANG ; Chan C.-C.; Collaborators of the Taiwan Community-Based Integrated Screening GroupGastroenterology34
52021The efficacy of Lactobacillus acidophilus and rhamnosus in the reduction of bacterial load of Helicobacter pylori and modification of gut microbiota—a double-blind, placebo-controlled, randomized trialChen M.-J.; Chen C.-C.; Huang Y.-C.; Tseng C.-C.; Hsu J.-T.; Lin Y.-F.; YU-JEN FANG ; Wu M.-S.; Liou J.-M.; for the Taiwan Gastrointestinal Disease, Helicobacter ConsortiumHelicobacter22
62021Sofosbuvir/velpatasvir plus ribavirin for child-pugh b and child-pugh c hepatitis c virus-related cirrhosisLiu C.-H.; Chen C.-Y.; Su W.-W.; Liu C.-J.; Lo C.-C.; Huang K.-J.; Chen J.-J.; Tseng K.-C.; Chang C.-Y.; Peng C.-Y.; Shih Y.-L.; Huang C.-S.; Kao W.-Y.; Yang S.-S.; Tsai M.-C.; Wu J.-H.; Chen P.-Y.; Su P.-Y.; Hwang J.-J.; YU-JEN FANG ; Lee P.-L.; Tseng C.-W.; Lee F.-J.; Lai H.-C.; Hsieh T.-Y.; Chang C.-C.; Chang C.-H.; Huang Y.-J.; Kao J.-H.Clinical and Molecular Hepatology03
72020Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairmentLiu C.-H.; Chen C.-Y.; Su W.-W.; Tseng K.-C.; Lo C.-C.; Liu C.-J.; Chen J.-J.; Peng C.-Y.; Shih Y.-L.; Yang S.-S.; Huang C.-S.; Huang K.-J.; Chang C.-Y.; Tsai M.-C.; Kao W.-Y.; YU-JEN FANG ; Chen P.-Y.; Su P.-Y.; Tseng C.-W.; Huang J.-J.; Lee P.-L.; Lai H.-C.; Hsieh T.-Y.; Chang C.-H.; Huang Y.-J.; Lee F.-J.; Chang C.-C.; Kao J.-H.Gut1214
82020Comparison of DNA stabilizers and storage conditions on preserving fecal microbiota profilesChen C.-C.; Wu W.-K.; Chang C.-M.; Panyod S.; Lu T.-P.; Liou J.-M.; YU-JEN FANG ; Chuang E.Y.; Wu M.-S.Journal of the Formosan Medical Association139
92020Application of Helicobacter pylori stool antigen test to survey the updated prevalence of Helicobacter pylori infection in TaiwanChen M.-J.; YU-JEN FANG ; Wu M.-S.; Chen C.-C.; Chen Y.-N.; Yu C.-C.; Kuo C.-C.; Chiu M.-C.; Hu W.-H.; Tsai M.-H.; Hsieh C.-L.; Chen H.-H.; Bair M.-J.; Liou J.-M.; for the Taiwan Gastrointestinal Disease; Helicobacter ConsortiumJournal of Gastroenterology and Hepatology (Australia)54
102020Accuracy of rapid Helicobacter pylori antigen tests for the surveillance of the updated prevalence of H. pylori in TaiwanYU-JEN FANG ; Chen M.-J.; Chen C.-C.; Lee J.-Y.; Yang T.-H.; Yu C.-C.; Chiu M.-C.; Kuo C.-C.; Weng Y.-J.; Bair M.-J.; Wu M.-S.; Luo J.-C.; Liou J.-M.Journal of the Formosan Medical Association75
112020Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysisLiu C.-H.; Peng C.-Y.; YU-JEN FANG ; Kao W.-Y.; Yang S.-S.; Lin C.-K.; Lai H.-C.; Su W.-P.; Fang S.-U.; Chang C.-C.; Su T.-H.; Liu C.-J.; Chen P.-J.; Chen D.-S.; Kao J.-H.Scientific Reports32
122020Microelimination of chronic hepatitis C by universal screening plus direct-acting antivirals for incarcerated persons in TaiwanYang T.-H.; YU-JEN FANG ; Hsu S.-J.; Lee J.-Y.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Chen C.-H.Open Forum Infectious Diseases1516
132020Comparison of the effect of clarithromycin triple therapy with or without N-acetylcysteine in the eradication of Helicobacter pylori: a randomized controlled trialChen C.-C.; Luo J.-C.; YU-JEN FANG ; Lee J.-Y.; Kuo C.-C.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Bair M.-J.; Chen P.-Y.; Chou C.-K.; Chen C.-Y.; Chang C.-Y.; Hsu Y.-C.; Tseng C.-H.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Hsieh C.-L.; Chen M.-J.; Shun C.-T.; Liu T.-Y.; Lee§ Y.-C.; Liou§ J.-M.; Wu§ M.-S.; and for the Taiwan Gastrointestinal Disease; Helicobacter ConsortiumTherapeutic Advances in Gastroenterology55
142019Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysisLiu C.-H.; Shih Y.-L.; Yang S.-S.; Lin C.-L.; YU-JEN FANG ; Cheng P.-N.; Chen C.-Y.; Peng C.-Y.; Hsieh T.-Y.; Chiu Y.-C.; Su T.-H.; Liu C.-J.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.Journal of Gastroenterology and Hepatology (Australia)66
152019Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trialLiou J.-M.; Chen C.-C.; Chang C.-M.; YU-JEN FANG ; Bair M.-J.; Chen P.-Y.; Chang C.-Y.; Hsu Y.-C.; Chen M.-J.; Chen C.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chen C.-Y.; Hsu W.-F.; Chen Y.-N.; Wu J.-Y.; Lin J.-T.; Lu T.-P.; Chuang E.Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter ConsortiumThe Lancet Infectious Diseases7272
162019Real-world effectiveness and safety of glecaprevir/pibrentasvir in Asian patients with chronic hepatitis CHsu S.-J.; Chiu M.-C.; YU-JEN FANG ; Yang T.-H.; Yu J.-J.; Chen C.-C.; Kuo C.-C.; Lee J.-Y.; Chen C.-H.; Chen D.-S.; Kao J.-H.Journal of the Formosan Medical Association1412
17201814 Day sequential therapy versus 10 day bismuth quadruple therapy containing high-dose esomeprazole in the first-line and second-line treatment of Helicobacter pylori: A multicentre, non-inferiority, randomized trialLiou J.-M.; Chen C.-C.; YU-JEN FANG ; Chen P.-Y.; Chang C.-Y.; Chou C.-K.; Chen M.-J.; Tseng C.-H.; Lee J.-Y.; Yang T.-H.; Chiu M.-C.; Yu J.-J.; Kuo C.-C.; Luo J.-C.; Hsu W.-F.; Hu W.-H.; Tsai M.-H.; Lin J.-T.; Shun C.-T.; Twu G.; Lee Y.-C.; Bair M.-J.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter ConsortiumJournal of Antimicrobial Chemotherapy99
182018Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori InfectionLiou J.-M.; Chen P.-Y.; Luo J.-C.; Lee J.-Y.; Chen C.-C.; YU-JEN FANG ; Yang T.-H.; Chang C.-Y.; Bair M.-J.; Chen M.-J.; Hsu Y.-C.; Hsu W.-F.; Chang C.-C.; Lin J.-T.; Shun C.-T.; El-Omar E.M.; Wu M.-S.; Liou J.-M.; Lee Y.-C.; Lin J.-T.; Wu C.-Y.; Wu J.-Y.; Chen C.-C.; Lin C.-H.; Fang Y.-R.; Bair M.-J.; Luo J.-C.; Cheng T.-Y.; Tseng P.-H.; Chiu H.-M.; Chang C.-C.; Yu C.-C.; Chiu M.-C.; Chen Y.-N.; Hu W.-H.; Chou C.-K.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Chang W.-S.; Taiwan Gastrointestinal Disease; Helicobacter ConsortiumGastroenterology4017
192018Systematic Review with Meta-Analysis: Concomitant Therapy vs. Triple Therapy for the First-Line Treatment of Helicobacter pylori InfectionChen M.-J.; Chen C.-C.; Chen Y.-N.; Chen C.-C.; YU-JEN FANG ; Lin J.-T.; Wu M.-S.; Liou J.-M.; for the Taiwan Gastrointestinal Disease; Helicobacter ConsortiumAmerican Journal of Gastroenterology2723
202017Impact of amoxicillin resistance on the efficacy of amoxicillincontaining regimens for Helicobacter pylori eradication: Analysis of five randomized trialsChen M.-J.; Wu M.-S.; Chen C.-C.; Chen C.-C.; YU-JEN FANG ; Bair M.-J.; Chang C.-Y.; Lee J.-Y.; Hsu W.-F.; Luo J.-C.; Lin J.-T.; Liou J.-M.; on behalf of the Taiwan Gastrointestinal Disease; Helicobacter ConsortiumJournal of Antimicrobial Chemotherapy1410
212017Hepatitis B virus reactivation in patients receiving interferon-free direct-acting antiviral agents for chronic hepatitis C virus infectionLiu C.-H.; Liu C.-J.; Su T.-H.; YU-JEN FANG ; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.Open Forum Infectious Diseases3836
222016Levofloxacin sequential therapy vs levofloxacin triple therapy in the second-line treatment of helicobacter pylori: A randomized trialLiou J.-M.; Bair M.-J.; Chen C.-C.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; YU-JEN FANG ; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Chang W.-H.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hung H.-W.; Lin J.-T.; Chang C.-Y.; Wu M.-S.American Journal of Gastroenterology3131
232016Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trialLiou J.-M.; YU-JEN FANG ; Chen C.-C.; Bair M.-J.; Chang C.-Y.; Lee Y.-C.; Chen M.-J.; Chen C.-C.; Tseng C.-H.; Hsu Y.-C.; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Chang C.-C.; Chen C.-Y.; Chen P.-Y.; Shun C.-T.; Hsu W.-F.; Hu W.-H.; Chen Y.-N.; Sheu B.-S.; Lin J.-T.; Wu J.-Y.; El-Omar E.M.; Wu M.-S.; Taiwan Gastrointestinal Disease; Helicobacter ConsortiumThe Lancet8783
242016Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of Helicobacter pylori in the community and hospital populations: A randomised trialLiou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; Chen C.-C.; YU-JEN FANG ; Lee J.-Y.; Yang T.-H.; Luo J.-C.; Wu J.-Y.; Liou T.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Chang C.-C.; Bair M.-J.; Liu T.-Y.; Hsieh C.-F.; Tsao F.-Y.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; Wu M.-S.; the Taiwan Gastrointestinal Disease; Helicobacter ConsortiumGut5450
252016Association Between Serum Level of Hepatitis B Surface Antigen at End of Entecavir Therapy and Risk of Relapse in E Antigen–Negative PatientsHsu Y.-C.; Mo L.-R.; Chang C.-Y.; Wu M.-S.; Kao J.-H.; Wang W.-L.; Yang T.-H.; Wang C.-S.; Chiang M.-F.; Chen C.-C.; YU-JEN FANG ; Hung H.-W.; Wu C.-Y.; Lin J.-T.Clinical Gastroenterology and Hepatology3029
262015Distinct aetiopathogenesis in subgroups of functional dyspepsia according to the Rome III criteriaYU-JEN FANG ; Liou J.-M.; Chen C.-C.; Lee J.-Y.; Hsu Y.-C.; Chen M.-J.; Tseng P.-H.; Chen C.-C.; Chang C.-Y.; Yang T.-H.; Chang W.-H.; Wu J.-Y.; Wang H.-P.; Luo J.-C.; Lin J.-T.; Shun C.-T.; Wu M.-S.Gut5748
272015The primary resistance of Helicobacter pylori in Taiwan after the national policy to restrict antibiotic consumption and its relation to virulence factors - A nationwide studyLiou J.-M.; Chang C.-Y.; Chen M.-J.; Chen C.-C.; YU-JEN FANG ; Lee J.-Y.; Wu J.-Y.; Luo J.-C.; Liou T.-C.; Chang W.-H.; Tseng C.-H.; Wu C.-Y.; Yang T.-H.; Chang C.-C.; Wang H.-P.; Sheu B.-S.; Lin J.-T.; Bair M.-J.; Wu M.-S.; Tai C.-M.; Lee C.-T.; Wang W.-L.; Lee Y.-C.; Wang Y.-C.; Taiwan Gastrointestinal Disease; Helicobacter ConsortiumPLoS ONE6263
282013Efficacy of genotypic resistance-guided sequential therapy in the third-line treatment of refractory Helicobacter pylori infection: A multicentre clinical trialLiou J.-M.; Chen C.-C.; Chang C.-Y.; Chen M.-J.; YU-JEN FANG ; Lee J.-Y.; Chen C.-C.; Hsu S.-J.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Chang L.; Chang W.-H.; Wang H.-P.; Shun C.-T.; Wu J.-Y.; Lee Y.-C.; Lin J.-T.; Wu M.-S.; Lin C.-H.; Chow L.-P.; Cheng T.-Y.; Wu C.-Y.; Lee Ching-Tai C.-T, Wang W.-L.; Tai C.-M.; Wang Y.-C.; Wang C.-H.; Kuo S.-H.; Wu C.-Y.Journal of Antimicrobial Chemotherapy6764
292013Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: A multicentre, open-label, randomised trialLiou J.-M.; Chen C.-C.; Chen M.-J.; Chen C.-C.; Chang C.-Y.; YU-JEN FANG ; Lee J.-Y.; Hsu S.-J.; Luo J.-C.; Chang W.-H.; Hsu Y.-C.; Tseng C.-H.; Tseng P.-H.; Wang H.-P.; Yang U.-C.; Shun C.-T.; Lin J.-T.; Lee Y.-C.; Wu M.-S.The Lancet202182
302012Suggested cutoff tumor size for management of small EUS-suspected gastric gastrointestinal stromal tumorsYU-JEN FANG ; Cheng T.-Y.; Sun M.-S.; Yang C.-S.; Chen J.-H.; Liao W.-C.; Wang H.-P.Journal of the Formosan Medical Association2222
312012Parvovirus B19 infection-related acute hepatitis after rituximab-containing regimen for treatment of diffuse large B-cell lymphomaYang S.-H.; Lin L.-W.; YU-JEN FANG ; Cheng A.-L.; Kuo S.-H.Annals of Hematology42
322012Randomised clinical trial: High-dose vs. standard-dose proton pump inhibitors for the prevention of recurrent haemorrhage after combined endoscopic haemostasis of bleeding peptic ulcersChen C.-C.; Lee J.-Y.; YU-JEN FANG ; Hsu S.-J.; Han M.-L.; Tseng P.-H.; Liou J.-M.; Hu F.-C.; Lin T.-L.; Wu M.-S.; Wang H.-P.; Lin J.-T.Alimentary Pharmacology and Therapeutics2926
332012Computer-generated surface and tone enhancements to distinguish neoplastic from non-neoplastic colon polyps less than 1 cm in diameterHan M.-L.; Lee Y.-C.; Chen C.-C.; YU-JEN FANG ; Lee J.-Y.; Lin T.-L.; Lin L.-W.; Tseng P.-H.; Wu M.-S.; Wang H.-P.International Journal of Colorectal Disease43
342011Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: A multicentre clinical trialLiou J.-M.; Chen C.-C.; Chen M.-J.; Chang C.-Y.; YU-JEN FANG ; Lee J.-Y.; Sheng W.-H.; Wang H.-P.; Wu M.-S.; Lin J.-T.Journal of Antimicrobial Chemotherapy3737
352009Barium appendicitisYU-JEN FANG ; Wang H.-P.; Ho C.-M.; Liu K.-L.Surgery1012
362008A rare diagnosis of right upper quadrant abdominal painChung C.-S.; Wang H.-P.; YU-JEN FANG ; Hu R.-H.; Hsiao J.-K.; Chen C.-G.H.Gut00